Mouse	mouse	O	O
strain-dependent	strain-dependent	O	O
effect	effect	O	O
of	of	O	O
amantadine	amantadine	S_chemical	O
on	on	O	O
motility	motility	O	O
and	and	O	O
brain	brain	O	O
biogenic	biogenic	B_chemical	O
amines	amines	I_chemical	O
.	.	O	O

The	the	O	O
effect	effect	O	O
of	of	O	O
amantadine	amantadine	B_chemical	O
hydrochloride	hydrochloride	I_chemical	O
,	,	O	O
injected	injected	O	O
i.p	i.p	O	O
.	.	O	O
in	in	O	O
6	6	O	O
increments	increments	O	O
of	of	O	O
100	100	O	O
mg/kg	mg/kg	O	O
each	each	O	O
over	over	O	O
30	30	O	O
hr	hr	O	O
,	,	O	O
on	on	O	O
mouse	mouse	O	O
motility	motility	O	O
and	and	O	O
whole	whole	O	O
brain	brain	O	O
content	content	O	O
of	of	O	O
selected	selected	O	O
biogenic	biogenic	B_chemical	O
amines	amines	I_chemical	O
and	and	O	O
major	major	O	O
metabolites	metabolites	O	O
was	was	O	O
studied	studied	O	O
in	in	O	O
4	4	O	O
strains	strains	O	O
of	of	O	O
mice	mice	O	O
.	.	O	O

These	these	O	O
were	were	O	O
the	the	O	O
albino	albino	O	O
Sprague-Dawley	sprague-dawley	O	O
ICR	icr	O	O
and	and	O	O
BALB/C	balb/c	O	O
,	,	O	O
the	the	O	O
black	black	O	O
C57BL/6	c57bl/6	O	O
and	and	O	O
the	the	O	O
brown	brown	O	O
CDF-I	cdf-i	O	O
mouse	mouse	O	O
strains	strains	O	O
.	.	O	O

Amantadine	amantadine	S_chemical	O
treatment	treatment	O	O
produced	produced	O	O
a	a	O	O
biphasic	biphasic	O	O
effect	effect	O	O
on	on	O	O
mouse	mouse	O	O
motility	motility	O	O
.	.	O	O

The	the	O	O
initial	initial	O	O
dose	dose	O	O
of	of	O	O
amantadine	amantadine	S_chemical	O
depressed	depressed	O	S_disease
locomotor	locomotor	O	O
activity	activity	O	O
in	in	O	O
all	all	O	O
mouse	mouse	O	O
strains	strains	O	O
studied	studied	O	O
with	with	O	O
the	the	O	O
BALB/C	balb/c	O	O
mice	mice	O	O
being	being	O	O
the	the	O	O
most	most	O	O
sensitive	sensitive	O	O
.	.	O	O

Subsequent	subsequent	O	O
amantadine	amantadine	S_chemical	O
treatments	treatments	O	O
produced	produced	O	O
enhancement	enhancement	O	O
of	of	O	O
motility	motility	O	O
from	from	O	O
corresponding	corresponding	O	O
control	control	O	O
in	in	O	O
all	all	O	O
mouse	mouse	O	O
strains	strains	O	O
with	with	O	O
the	the	O	O
BALB/C	balb/c	O	O
mice	mice	O	O
being	being	O	O
the	the	O	O
least	least	O	O
sensitive	sensitive	O	O
.	.	O	O

The	the	O	O
locomotor	locomotor	O	O
activity	activity	O	O
was	was	O	O
decreased	decreased	O	O
from	from	O	O
corresponding	corresponding	O	O
controls	controls	O	O
in	in	O	O
all	all	O	O
strains	strains	O	O
studied	studied	O	O
,	,	O	O
except	except	O	O
for	for	O	O
the	the	O	O
ICR	icr	O	O
mice	mice	O	O
,	,	O	O
during	during	O	O
an	an	O	O
overnight	overnight	O	O
drug-free	drug-free	O	O
period	period	O	O
following	following	O	O
the	the	O	O
fourth	fourth	O	O
amantadine	amantadine	S_chemical	O
treatment	treatment	O	O
.	.	O	O

Readministration	readministration	O	O
of	of	O	O
amantadine	amantadine	S_chemical	O
,	,	O	O
after	after	O	O
a	a	O	O
drug-free	drug-free	O	O
overnight	overnight	O	O
period	period	O	O
,	,	O	O
increased	increased	O	O
motility	motility	O	O
from	from	O	O
respective	respective	O	O
saline	saline	O	O
control	control	O	O
in	in	O	O
all	all	O	O
strains	strains	O	O
with	with	O	O
exception	exception	O	O
of	of	O	O
the	the	O	O
BALB/C	balb/c	O	O
mice	mice	O	O
where	where	O	O
suppression	suppression	O	O
of	of	O	O
motility	motility	O	O
occurred	occurred	O	O
.	.	O	O

Treatment	treatment	O	O
with	with	O	O
amantadine	amantadine	S_chemical	O
did	did	O	O
not	not	O	O
alter	alter	O	O
whole	whole	O	O
brain	brain	O	O
dopamine	dopamine	S_chemical	O
levels	levels	O	O
but	but	O	O
decreased	decreased	O	O
the	the	O	O
amounts	amounts	O	O
of	of	O	O
3,4-dihydroxyphenylacetic	3,4-dihydroxyphenylacetic	B_chemical	O
acid	acid	I_chemical	O
in	in	O	O
the	the	O	O
BALB/C	balb/c	O	O
mice	mice	O	O
compared	compared	O	O
to	to	O	O
saline	saline	O	O
control	control	O	O
.	.	O	O

Conversely	conversely	O	O
,	,	O	O
brain	brain	O	O
normetanephrine	normetanephrine	S_chemical	O
concentration	concentration	O	O
was	was	O	O
increased	increased	O	O
from	from	O	O
saline	saline	O	O
control	control	O	O
by	by	O	O
amantadine	amantadine	S_chemical	O
in	in	O	O
the	the	O	O
BALB/C	balb/c	O	O
mice	mice	O	O
.	.	O	O

The	the	O	O
results	results	O	O
suggest	suggest	O	O
a	a	O	O
strain-dependent	strain-dependent	O	O
effect	effect	O	O
of	of	O	O
amantadine	amantadine	S_chemical	O
on	on	O	O
motility	motility	O	O
and	and	O	O
indicate	indicate	O	O
a	a	O	O
differential	differential	O	O
response	response	O	O
to	to	O	O
the	the	O	O
acute	acute	O	O
and	and	O	O
multiple	multiple	O	O
dose	dose	O	O
regimens	regimens	O	O
used	used	O	O
.	.	O	O

The	the	O	O
BALB/C	balb/c	O	O
mouse	mouse	O	O
was	was	O	O
the	the	O	O
most	most	O	O
sensitive	sensitive	O	O
strain	strain	O	O
and	and	O	O
could	could	O	O
serve	serve	O	O
as	as	O	O
the	the	O	O
strain	strain	O	O
of	of	O	O
choice	choice	O	O
for	for	O	O
evaluating	evaluating	O	O
the	the	O	O
side	side	O	B_disease
effects	effects	O	I_disease
of	of	O	O
amantadine	amantadine	S_chemical	O
.	.	O	O

The	the	O	O
biochemical	biochemical	O	O
results	results	O	O
of	of	O	O
brain	brain	O	O
biogenic	biogenic	B_chemical	O
amines	amines	I_chemical	O
of	of	O	O
BALB/C	balb/c	O	O
mouse	mouse	O	O
strain	strain	O	O
suggest	suggest	O	O
a	a	O	O
probable	probable	O	O
decrease	decrease	O	O
of	of	O	O
catecholamine	catecholamine	S_chemical	O
turnover	turnover	O	O
rate	rate	O	O
and/or	and/or	O	O
metabolism	metabolism	O	O
by	by	O	O
monoamine	monoamine	B_chemical	O
oxidase	oxidase	I_chemical	O
and	and	O	O
a	a	O	O
resulting	resulting	O	O
increase	increase	O	O
in	in	O	O
O-methylation	o-methylation	O	O
of	of	O	O
norepinephrine	norepinephrine	S_chemical	O
which	which	O	O
may	may	O	O
account	account	O	O
for	for	O	O
a	a	O	O
behavioral	behavioral	O	O
depression	depression	O	S_disease
caused	caused	O	O
by	by	O	O
amantadine	amantadine	S_chemical	O
in	in	O	O
the	the	O	O
BALB/C	balb/c	O	O
mice	mice	O	O
.	.	O	O

